Abstract
Stroke investigators have made great progress in defining the neurochemical consequences of brain ischemia, as well as providing a scientific foundation for the medical and surgical therapies of secondary stroke prevention. Nevertheless, it is striking that relatively little is known of the initiating process of the clinical event constituting stroke. This process, lacking precise characterization, is typically referred to as ’hypoperfusion’ or ’embolization’. Current neurodiagnostic technology has blurred, rather than clarified, this distinction. An example of this phenomenon comes from the landmark North American Symptomatic Carotid Endarterectomy Trial, in which the efficacy of surgical removal of symptomatic carotid plaques appeared to be directly related to the degree of hemodynamic compromise produced by these lesions (NASCET Collaborators 1991). Yet angiography performed in the first hours after stroke commonly shows possible embolic occlusion distal to carotid stenosis (del Zoppo et al. 1992).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ameriso SF, Paganini-Hill A, Meiselman HJ, Fisher M (1990) Correlates of middle cerebral artery blood flow velocity in the elderly. Stroke 21: 1579–1583
Ameriso SF, Wong VLY, Quismorio FP, Fisher M (1991) Immunohematologic characteristics of infection-associated cerebral infarction. Stroke 22: 1004–1009
Ameriso SF, Sager P, Fisher M (1992) Atrial fibrillation, congestive heart failure, and the middle cerebral artery: an ultrasound analysis. J Neuroimag 2: 190–194
Bauer KA, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD (1989) Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 74: 165–172
Benveniste EN (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanisms of action. Am J Physiol 263 (Cell Physiol) 32: C1–C16
Bernard JT, Ameriso S, Kempf RA, Rosen P, Mitchell MS, Fisher M (1990) Transient focal neurologic deficits complicating interleukin-2 therapy. Neurology 40: 154–155
Boey ML, Colaco CB, Gharavi AE, Elkon KB, Loizou S, Hughes GRV (1983) Thrombosis in SLE: striking association with the presence of circulating ’lupus’ anticoagulant. Br Med J 287: 1021–1023
Chung IY, Norris JG, Benveniste EN (1991) Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and –resistant rat strains. J Exp Med 173: 801–811
Conway EM, Bach R, Rosenberg RD, Konigsberg WH (1989) Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb Res 53: 231–241
Coull BM, Levine SR, Brey RL (1992) The role of antiphospholipid antibodies in stroke. Neurol Clin 10: 125–142
De Agostini Al, Watkins SC, Slayter HS, Youssoufian H, Rosenberg RD (1990) Localization of anticoagulantly active heparin sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta. J Cell Biol 111: 1293–1304
del Zoppo G, Poeck K, Pessin MS et al (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86
Drake TA, Morrissey JH, Edgington TS (1989) Selective eelhilar expression of tissue factor in human tissues. Am J Pathol 134: 1087–1097
Eddleston M, de la Torre JC, Oldstone MBA, Loskutoff DJ,Edgington TS, Mackman N (1993) Astrocytes are the primary source of tissue factor in the murine central nervous system. J Clin Invest 92: 349–358
Esmon CT, Taylor FB, Snow TR (1991) Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 66: 160–165
Falk E (1985) Unstable angina with fatal outcome: dynamic thrombosis leading to infarction and/or sudden death. Circulation 71: 699–708
Fisher M, Francis R (1990) Altered coagulation in cerebral ischemia: platelet, thrombin, and plasmin activity. Arch Neurol 47: 1075–1079
Fleck RA, Rao LVM, Rapaport SI, Varki N (1990) Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 57: 765–781
Freyssinet JM, Cazenave JP (1987) Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis. Thromb Haemost 58: 679–681
Furie B, Furie BC (1992) Molecular and cellular biology of blood coagulation. New Engl J Med 326: 800–806
Gershenwald JE, Fong Y, Fahey TJ et al. (1990) Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 87: 4966–4970
Grotta J, Ackerman R, Correia J, Fallick G, Chang J (1982) Whole blood viscosity parameters and cerebral blood flow. Stroke 13: 296–301
Grotta JC, Yatsu FM, Pettigrew LC (1989) Prediction of carotid stenosis by lipid and hematologic measurements. Neurology 39: 1325–1331
Hacke W, Zeumer H, Ferbert A et al. (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebro-basilar occlusive disease. Stroke 19: 1216–1222
Hallenbeck JM, Dutka AJ, Kochanek PM, Siren A, Pezeshpour GH, Feuerstein G (1988) Stroke risk factors prepare brainstem tissues for modified local Shwartzman reaction. Stroke 19: 863–869
Hallenbeck JM, Dutka AH, Vogel SN, Heldman E, Doron D, Feuerstein G (1991) Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke. Brain Res 541: 115–120
Hass WK, Easton JD, Adams HP et al. (1989) A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New Engl J Med 321: 501–507
Kalderon N, Ahonen K, Federoff S (1990) Developmental transition in plasticity properties of differentiating astrocytes: age-related biochemical profile of plasminogen activators in astroglial cultures. Glia 3: 413–426
Kannel WB, Wolf PA, Castelli WP, D’Agostino RB (1987) Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA 258: 1183–1186
Krystosek A, Seeds NW (1981) Plasminogen activator release at the neuronal growth cone. Science 213: 1532–1534
Lee RJ, Bartzokis T, Yeoh TK, Grogin H, Choi D, Schnittger I (1991) Enhanced detection of intracardiac sources of cerebral emboli by transesophageal echocardiography. Stroke 22: 734–739
Love PE, Santoro SA (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus ( SLE) and in non-SLE disorders. Ann Intern Med 112: 682–698
Marsh E, Biller J, Adams H et al (1990) Circadian variation in onset of acute ischemic stroke. Arch Neurol 47: 1178–1180
Myers MA, Fleck A (1988) Observations on the delay in onset of the acute phase protein response. Br J Exp Pathol 69: 169–176
North American Symptomatic Carotid Endarterectomy Trial Collaborators (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. New Engl J Med 325: 445–453
Petersen P, Kastrup J, Videbaek R, Boysen G (1989) Cerebral blood flow before and after cardioversion of atrial fibrillation. J Cerebr Blood Flow Metab 9: 422–425
Sandset PM, Warn-Cramer BJ, Maki SL, Rapaport SI (1992) Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction. Blood 78: 1496–1502
Scarpati EM, Sadler JE (1989) Regulation of endothelial cell coagulant properties. J Biol Chem 264: 20705–20713
Schorer AE, Wickham NWR, Watson KV (1989) Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation. Br J Haematol 71: 399–407
Siebler M, Sitzer M, Steinmetz H (1992) Detection of intracranial emboli in patients with symptomatic extracranial carotid artery disease. Stroke 23: 1652–1654
Siren AL, Heldman E, Doron D et al (1992) Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Stroke 23: 1643–1651
Sloan DJ, Wood MJ, Charlton HM (1992) Leukocyte recruitment and inflammation in the CNS. TINS 15: 276–280
Snow TR, Deal MT, Dickey DT, Esmon CT (1991) Protein C activation following coronary artery occlusion in the in situ porcine heart. Circulation 84: 293–299
Suffredini AF, Harpel PC, Parrillo JE (1989) Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. New Engl J Med 320: 1165–1172
Syrjanen J, Valtonen W, Iivanainen M, Kaste M, Huttunen JK (1988) Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J 296: 1156–1160
Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. New Engl J Med 311: 501–505
Wong VLY, Hofman F, Ishii H, Fisher M (1991) Regional distribution of thrombomodulin in human brain. Brain Res 556: 1–5
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag London Limited
About this chapter
Cite this chapter
Fisher, M.J. (1995). Immunohematologic Mechanisms in Stroke. In: Caplan, L.R. (eds) Brain Ischemia. Springer, London. https://doi.org/10.1007/978-1-4471-2073-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2073-5_13
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2075-9
Online ISBN: 978-1-4471-2073-5
eBook Packages: Springer Book Archive